RVL Pharmaceuticals (FRA:O1P) Ending Cash Position : €17.68 Mil (As of Jun. 2023)

View and export this data going back to 2018. Start your Free Trial

What is RVL Pharmaceuticals Ending Cash Position?

RVL Pharmaceuticals's Ending Cash Position for the quarter that ended in Jun. 2023 was €17.68 Mil.

RVL Pharmaceuticals's quarterly Ending Cash Position declined from Dec. 2022 (€42.05 Mil) to Mar. 2023 (€30.49 Mil) and declined from Mar. 2023 (€30.49 Mil) to Jun. 2023 (€17.68 Mil).

RVL Pharmaceuticals's annual Ending Cash Position declined from Dec. 2020 (€93.75 Mil) to Dec. 2021 (€35.79 Mil) but then increased from Dec. 2021 (€35.79 Mil) to Dec. 2022 (€42.05 Mil).

RVL Pharmaceuticals Ending Cash Position Historical Data

The historical data trend for RVL Pharmaceuticals's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RVL Pharmaceuticals Ending Cash Position Chart

RVL Pharmaceuticals Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Ending Cash Position

Get a 7-Day Free Trial

62.26

86.28

93.75

35.79

42.05

RVL Pharmaceuticals Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Ending Cash Position	Get a 7-Day Free Trial															25.93	60.35	42.05	30.49	17.68

RVL Pharmaceuticals Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

RVL Pharmaceuticals's Ending Cash Position for the fiscal year that ended in Dec. 2022 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	38.18	+	3.869
	=	42.05

RVL Pharmaceuticals's Ending Cash Position for the quarter that ended in Jun. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	30.127	+	-12.443
	=	17.68

RVL Pharmaceuticals Ending Cash Position Related Terms

Thank you for viewing the detailed overview of RVL Pharmaceuticals's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

RVL Pharmaceuticals (FRA:O1P) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » RVL Pharmaceuticals PLC (FRA:O1P) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

RVLPQ:USA

Address

400 Crossing Boulevard, Bridgewater, NJ, USA, 08807

Website

https://www.rvlpharma.com

RVL Pharmaceuticals PLC is a pharmaceutical company focused on the commercialization and development of products that target markets with underserved patient populations in the ocular medicine and medical aesthetics therapeutic areas. Its revenues consist of product sales, royalty revenues and licensing revenue.

RVL Pharmaceuticals (FRA:O1P) Headlines

No Headlines